Navigation Links
Study Shows Pine Bark Reduces Jetlag

Pycnogenol(R) cut jetlag symptoms in half for passengers taking 7- to

9-hour flights

HOBOKEN, N.J., Nov. 5 /PRNewswire/ -- A new study published in the journal of Minerva Cardioangiologica reveals Pycnogenol(R), pine bark extract from the French maritime pine tree, reduces jetlag in passengers by nearly 50 percent. The two-part study, consisting of a brain CT scan and a scoring system, showed Pycnogenol(R) lowered symptoms of jetlag such as fatigue, headaches, insomnia and brain edema (swelling) in both healthy individuals and hypertensive patients. Passengers also experienced minimal lower leg edema, a common condition associated with long flights.

Jetlag, also called desynchronosis, is a temporary disorder that causes a variety of temporary mental and physical impairments as a result of air travel across time zones -- common in flights to Asia and Europe, but also observed in travelers between West and East coast. It is caused due to the body's inability to immediately adjust to the time in a different zone while travelling. As the body struggles to cope with the new schedule, temporary conditions such as insomnia, fatigue, irritability and an impaired ability to concentrate may set in.

"This study could not have come at a better time for the upcoming holiday travel season," said Dr. Gianni Belcaro, a lead researcher of the study. Belcaro attributes Pycnogenol's(R) combined activities for better circulation and antioxidant potency to such remarkable results. "Previous Pycnogenol(R) flight studies have shown a reduction in jetlag; however this was the first study to solely focus on the condition."

The study, conducted at the G. D'Annunzio University in Pescara, Italy, consisted of 133 passengers who took flights that were seven to nine hours in length. Fifty mg of oral Pycnogenol(R) was administered three times daily, for seven days, starting two days prior to the flight.

Patients in the first part of the study were evaluated with a rating scale consisting of a scoring system. Thirty-eight Pycnogenol(R)-treated and 30 control patients were rated on the most common complaints of jetlag: dehydration and loss of appetite; headaches and/or sinus irritation; fatigue; disorientation and/or grogginess; nausea and/or upset stomach; insomnia and/or highly irregular sleep patterns; irritability; irrational behavior; alternation in mental performance (easy crossword); alternations in general wellbeing; hours of duration of any signs/symptoms; and nights of altered/disturbed sleep. Observations were measured and taken within 48 hours after the end of the flights. Results showed a significantly lower score (56 percent) in the Pycnogenol(R) group for all items rated, amounting in a significant reduction of all jetlag signs and symptoms. Moreover, symptoms lasted only for an average of 18.2 hours in the Pycnogenol(R) group as compared to 39.3 hours in the control group.

In a second group of flight passengers, a brain CT scan was performed after the flight in order to assess brain alterations after flights. The study consisted of 34 Pycnogenol(R)-treated patients and 31 controlled patients. Jetlag symptoms were evaluated using a rating scale providing scores according to the severity. The first observation was performed within 28 hours from the end of the flight. Sleep alterations, short-term memory alterations, disorientation, neurological signs/symptoms of instability, anxiety, minor cardiac alterations (heart rate, blood pressure), lower limb swelling, fatigue and other, a-specific signs/symptoms (cramps, joints/muscular pain, blurred vision, vertigo, mild sickness, increase in body temperature, appetite loss, headache, mild tongue swelling) were all significantly lower by in average 61.5% in the Pycnogenol(R) group compared to the untreated control group.

"This is the first study describing diffuse subliminal swellings of the brain after long haul flights, which we found to be reduced to less than half in the Pycnogenol(R) group," said Dr. Belcaro

"I'm encouraged by the results of the study as Pycnogenol(R) was effective in preventing jetlag related effects without any side-effects," said Dr. Belcaro. While more research needs to be conducted on this topic, Pycnogenol(R) is emerging as natural, yet safe option for long distance travelers.

Pycnogenol(R) has been shown to be beneficial for flight travel in previous studies pertaining to edema, deep vein thrombosis (DVT) and blood circulation improvement. A study published in Clinical Applied Thrombosis/Hemostasis recorded passengers supplementing with Pycnogenol(R) on long distance flights lasting 7-12 hours were significantly protected from thrombotic events, complications resulting from deep vein thrombosis (DVT) and superficial vein thrombosis (SVT). In 2005, a study published in Clinical and Applied Thrombosis/Hemostasis showed Pycnogenol(R) to be effective in reducing leg and ankle swelling (edema) during long airplane flights lasting seven to 12 hours.

About Pycnogenol(R)

Pycnogenol(R) is a natural plant extract originating from the bark of the maritime pine that grows along the coast of southwest France and is found to contain a unique combination of procyanidins, bioflavonoids and organic acids, which offer extensive natural health benefits. The extract has been widely studied for the past 35 years and has more than 220 published studies and review articles ensuring safety and efficacy as an ingredient. Today, Pycnogenol(R) is available in more than 600 dietary supplements, multi-vitamins and health products worldwide. For more information, visit

Natural Health Science Inc. (NHS), based in Hoboken, New Jersey, is the North American distributor for Pycnogenol(R) (pic-noj-en-all) brand French maritime pine bark extract on behalf of Horphag Research. Pycnogenol(R) is a registered trademark of Horphag Research Ltd., Guernsey, and its applications are protected by U.S. patents #5,720,956 / #6,372,266 and other international patents. NHS has the exclusive rights to market and sell Pycnogenol(R) in North America and benefits from more than 35 years of scientific research assuring the safety and efficacy of Pycnogenol(R) as a dietary supplement. For more information about Pycnogenol(R) visit our Web site at

SOURCE Natural Health Science Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Study Shows Hispanics Prefer Beer
2. Impact of insulin pump under study
3. New Study Provides Benchmarks for Fixed-Dose Combination (FDC) Drug Development
4. Misonix Subsidiary, Sonora Medical Systems, Announces a Major Ultrasound Probe Study
5. Study finds ADHD affects motor skills of boys more than girls
6. Media Spotlight Shines on Dr. Siegals Cookie Diet While Major Study Reveals Doubling of U.S. Type II Diabetes Cases During Past Ten Years
7. AMA Journal Publishes Study Showing Evidence of a Major Environmental Trigger For Autism
8. Study Sheds Light on Painkillers Heart Risk
9. GSU study first to confirm long-term benefits of morphine treatment in infants
10. Study finds fears of HIV transmission in families with infected parent
11. Moores UCSD Cancer Center studying novel leukemia vaccine for high-risk patients
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... Scott Newman MD, ... a select few plastic surgeons in the New York City area to utilize ... the world’s first heat-induced laser treatment for fat loss in the abdomen, flanks, ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... a leading provider of enterprise Time and Attendance/Workforce Management cloud-based solutions, announced ... Microsoft Partner Program with competencies in the Application Development, demonstrating a “best-in-class” ...
(Date:11/30/2015)... ... 30, 2015 , ... Workstation solutions provider , HealthPostures, ... dealers located throughout the United States, is OneStop Ergonomics. The addition allows HealthPostures ... and government workers and organizational leaders that are introduced to innovative methods that ...
(Date:11/30/2015)... ... November 30, 2015 , ... CTI Group (Holdings) ... empower organizations through communication analytics, announced today that their Proteus® VoIP QMS solution ... service quality. , Proteus® VoIP QMS (Quality Management System) does this ...
(Date:11/29/2015)... ... November 30, 2015 , ... The Cyber Monday deal is a deep 40% or ... right time to get gifts for the skin care lover in your circle. Each ... serums . This year, the 3 serums are staples: Collagen, Retinol and Hyaluronic Serums. , ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... the Six Months Ended 30 September 2015 2014RestatedChange%Turnover 545,575 , 518,852 ... , 384,242 , 9.8 Hospital Management ... , (18.3) Medical Insurance Administration Service Income , ... Medical Devices and Accessories Sales , 89,645 , ... 2,822 , 2,917 , (3.3) ...
(Date:11/30/2015)... 2015  Kevin Smith has been appointed Chief ... pioneer in wireless monitoring of vital signs.  As ... , Mr. Smith will be responsible for the ... He will also directly oversee partnering with US ... for SensiumVitals, the first early warning detection device ...
(Date:11/30/2015)... India , November 30, 2015 ... market research report "Dental Lasers Market by Product (Soft Tissue, ... Periodontitis), End User (Hospitals, Clinics), and Geography - Global Forecast ... 224.7 Million by 2020, at a CAGR of 5.2% during ... Browse 140 market data Tables and 62 Figures spread through ...
Breaking Medicine Technology: